Topography of cerebral monoamine transporter availability in families with SCA2 mutations: a voxel-wise [123I]β-CIT SPECT analysis

[1]  I. Podreka,et al.  β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo , 2005, Journal of Neural Transmission / General Section JNT.

[2]  E. Länsimies,et al.  The dosimetry of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane , 2004, European Journal of Nuclear Medicine.

[3]  Changming Sun,et al.  Spinocerebellar ataxia type 2 presenting as familial levodopa‐responsive parkinsonism , 2001, Annals of neurology.

[4]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.

[5]  Michael Schocke,et al.  Atrophy pattern in SCA2 determined by voxel-based morphometry , 2003, Neuroreport.

[6]  C. Halldin,et al.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.

[7]  V J Cunningham,et al.  Quantification in positron emission tomography for research in pharmacology and drug development. , 2004, Nuclear medicine communications.

[8]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[9]  A. Kojima,et al.  Effect of spatial resolution on SPECT quantification values. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M. T. Pellecchia,et al.  Reduced striatal [123I]FP‐CIT binding in SCA2 patients without parkinsonism , 2004, Annals of neurology.

[11]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[12]  P B Hoffer,et al.  [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. , 1991, Journal of medicinal chemistry.

[13]  J. Dichgans,et al.  Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[14]  J Tauscher,et al.  Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Robert B. Innis,et al.  Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  W. Poewe,et al.  Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I‐βCIT and 123I‐IBZM SPECT study , 2004, Movement disorders : official journal of the Movement Disorder Society.

[17]  M. Kuhar,et al.  [125I]RTI-55: a potent ligand for dopamine transporters. , 1991, European journal of pharmacology.

[18]  Georg Auburger,et al.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2 , 1996, Nature Genetics.

[19]  B. Djahanguiri,et al.  The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.

[20]  Werner Poewe,et al.  Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice , 2003, Movement disorders : official journal of the Movement Disorder Society.

[21]  Georg Auburger,et al.  Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies , 1999, Acta Neuropathologica.

[22]  A Dürr,et al.  Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. , 1995, Brain : a journal of neurology.

[23]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[24]  S. Tsuji,et al.  Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT , 1996, Nature Genetics.

[25]  P. Lockhart,et al.  SCA-2 presenting as parkinsonism in an Alberta family , 2002, Neurology.

[26]  Karl J. Friston,et al.  Spatial registration and normalization of images , 1995 .

[27]  THE NONLINEAR PARTIAL VOLUME ARTIFACT , 1979 .

[28]  David Eidelberg,et al.  The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson’s disease and multiple system atrophy , 2004, Clinical Autonomic Research.

[29]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[30]  M Laruelle,et al.  Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT. , 1991, European journal of pharmacology.

[31]  Karl J. Friston,et al.  Image registration using a symmetric prior—in three dimensions , 1999, Human brain mapping.

[32]  D. Brooks,et al.  [123I]β-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson’s disease and multiple system atrophy , 2003, Nuklearmedizin.

[33]  G. Uhl.  Neurotransmitter transporters (plus): a promising new gene family , 1992, Trends in Neurosciences.

[34]  Alan C. Evans,et al.  Enhancement of MR Images Using Registration for Signal Averaging , 1998, Journal of Computer Assisted Tomography.

[35]  E. Ryding,et al.  A new model for separation between brain dopamine and serotonin transporters in 123I-β-CIT SPECT measurements: normal values and sex and age dependence , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  Klaus Seppi,et al.  Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. , 2005, Brain : a journal of neurology.

[37]  D. Mash,et al.  Visualizing Dopamine and Serotonin Transporters in the Human Brain with the Potent Cocaine Analogue [125I]RTI‐55: In Vitro Binding and Autoradiographic Characterization , 1994, Journal of neurochemistry.

[38]  C. Halldin,et al.  Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2 , 2005, European Neuropsychopharmacology.

[39]  M Skalej,et al.  Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. , 1998, Brain : a journal of neurology.

[40]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[41]  Stefan M Pulst,et al.  Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. , 2003, Human molecular genetics.

[42]  Yves Agid,et al.  Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats , 1996, Nature Genetics.

[43]  D. Guilloteau,et al.  Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I , 1999, NeuroImage.